According to the research report, the global market for Group A and Group C Meningococcal Polysaccharide Vaccine should grow from US$ 285 million in 2022 to US$ 425.5 million by 2029, with a CAGR of 5.9% for the period of 2023-2029.

Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.

After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.

This report studies and analyses global Group A and Group C Meningococcal Polysaccharide Vaccine status and future trends, helps the client to determine the Group A and Group C Meningococcal Polysaccharide Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Group A and Group C Meningococcal Polysaccharide Vaccine, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Group A and Group C Meningococcal Polysaccharide Vaccine market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Group A and Group C Meningococcal Polysaccharide Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Group A and Group C Meningococcal Polysaccharide Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Group A and Group C Meningococcal Polysaccharide Vaccine key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Group A and Group C Meningococcal Polysaccharide Vaccine key producing regions, capacity, production, and year over year growth

(6) Group A and Group C Meningococcal Polysaccharide Vaccine industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Walvax

Lanzhou Institute of Biological Products

AIM Bio

Sanofi Pasteur

GSK

Hualan Bio

ZFSW

Changsheng

Kanghua Bio

Market segment by Type, covers

Class 1 Vaccine

Class II Vaccine

Market segment by Application, can be divided into

Hospital

Clinic

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Group A and Group C Meningococcal Polysaccharide Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Group A and Group C Meningococcal Polysaccharide Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Group A and Group C Meningococcal Polysaccharide Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Group A and Group C Meningococcal Polysaccharide Vaccine, percent & CAGR, 2018-2029

Chapter 5: Group A and Group C Meningococcal Polysaccharide Vaccine industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Definition

1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast

1.2.1 By Consumption Value, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029

1.2.2 By Sales Quantity, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029

1.2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP)，2018-2029

1.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast

1.3.1 By Consumption Value, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029

1.3.2 By Sales Quantity, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029

1.3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP)， 2018-2029

1.4 Share of China Group A and Group C Meningococcal Polysaccharide Vaccine Market with Respect to the Global Market

1.4.1 By Consumption Value, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share in Global, 2018-2029

1.4.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market Size: China VS Global, 2018-2029

1.5 Group A and Group C Meningococcal Polysaccharide Vaccine Market Dynamics

1.5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers

1.5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints

1.5.3 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Trends

1.5.4 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Group A and Group C Meningococcal Polysaccharide Vaccine, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of Group A and Group C Meningococcal Polysaccharide Vaccine, Global Market Share by Company, 2018-2023

2.3 Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Company, 2018-2023

2.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Concentration Ratio

2.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type

2.8 Head Office and Group A and Group C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer

2.9 Group A and Group C Meningococcal Polysaccharide Vaccine Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Group A and Group C Meningococcal Polysaccharide Vaccine, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of Group A and Group C Meningococcal Polysaccharide Vaccine, China Market Share by Company, 2018-2023

3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity by Region

4.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2029

4.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain

5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Analysis

5.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Group A and Group C Meningococcal Polysaccharide Vaccine Production Mode

5.6 Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model

5.7 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels

5.7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model

5.7.2 Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors

6 Sights by Type

6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Classification

6.1.1 Class 1 Vaccine

6.1.2 Class II Vaccine

6.2 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029

6.4 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029

6.5 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029

7.4 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029

7.5 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029

8.3 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine & Forecasts, 2018-2029

8.4.2 By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029

9.3 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.4.2 By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.5.2 By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.6.2 By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.7.2 By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.8.2 By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.9.2 By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.10.2 By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Walvax

10.1.1 Walvax Company Information, Head Office, Market Area, and Industry Position

10.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Walvax Company Profile and Main Business

10.1.5 Walvax Recent Developments

10.2 Lanzhou Institute of Biological Products

10.2.1 Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position

10.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Lanzhou Institute of Biological Products Company Profile and Main Business

10.2.5 Lanzhou Institute of Biological Products Recent Developments

10.3 AIM Bio

10.3.1 AIM Bio Company Information, Head Office, Market Area, and Industry Position

10.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 AIM Bio Company Profile and Main Business

10.3.5 AIM Bio Recent Developments

10.4 Sanofi Pasteur

10.4.1 Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position

10.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Sanofi Pasteur Company Profile and Main Business

10.4.5 Sanofi Pasteur Recent Developments

10.5 GSK

10.5.1 GSK Company Information, Head Office, Market Area, and Industry Position

10.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 GSK Company Profile and Main Business

10.5.5 GSK Recent Developments

10.6 Hualan Bio

10.6.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position

10.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Hualan Bio Company Profile and Main Business

10.6.5 Hualan Bio Recent Developments

10.7 ZFSW

10.7.1 ZFSW Company Information, Head Office, Market Area, and Industry Position

10.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 ZFSW Company Profile and Main Business

10.7.5 ZFSW Recent Developments

10.8 Changsheng

10.8.1 Changsheng Company Information, Head Office, Market Area, and Industry Position

10.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Changsheng Company Profile and Main Business

10.8.5 Changsheng Recent Developments

10.9 Kanghua Bio

10.9.1 Kanghua Bio Company Information, Head Office, Market Area, and Industry Position

10.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

10.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Kanghua Bio Company Profile and Main Business

10.9.5 Kanghua Bio Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints

Table 3. Group A and Group C Meningococcal Polysaccharide Vaccine Market Trends

Table 4. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy

Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type

Table 13. Head Office and Group A and Group C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer

Table 14. Group A and Group C Meningococcal Polysaccharide Vaccine Capacity of Major Manufacturers and Future Plan

Table 15. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2023, (K Units)

Table 20. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Group A and Group C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)

Table 22. Global Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers

Table 23. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors

Table 24. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029

Table 34. Walvax Company Information, Head Office, Market Area, and Industry Position

Table 35. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 36. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Walvax Company Profile and Main Business

Table 38. Walvax Recent Developments

Table 39. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 40. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 41. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Lanzhou Institute of Biological Products Company Profile and Main Business

Table 43. Lanzhou Institute of Biological Products Recent Developments

Table 44. AIM Bio Company Information, Head Office, Market Area, and Industry Position

Table 45. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 46. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. AIM Bio Company Profile and Main Business

Table 48. AIM Bio Recent Developments

Table 49. Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position

Table 50. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 51. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Sanofi Pasteur Company Profile and Main Business

Table 53. Sanofi Pasteur Recent Developments

Table 54. GSK Company Information, Head Office, Market Area, and Industry Position

Table 55. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 56. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. GSK Company Profile and Main Business

Table 58. GSK Recent Developments

Table 59. Hualan Bio Company Information, Head Office, Market Area, and Industry Position

Table 60. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 61. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Hualan Bio Company Profile and Main Business

Table 63. Hualan Bio Recent Developments

Table 64. ZFSW Company Information, Head Office, Market Area, and Industry Position

Table 65. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 66. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. ZFSW Company Profile and Main Business

Table 68. ZFSW Recent Developments

Table 69. Changsheng Company Information, Head Office, Market Area, and Industry Position

Table 70. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 71. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Changsheng Company Profile and Main Business

Table 73. Changsheng Recent Developments

Table 74. Kanghua Bio Company Information, Head Office, Market Area, and Industry Position

Table 75. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application

Table 76. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Kanghua Bio Company Profile and Main Business

Table 78. Kanghua Bio Recent Developments

List of Figures

Figure 1. Group A and Group C Meningococcal Polysaccharide Vaccine Picture

Figure 2. Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units) & (2018-2029)

Figure 7. China Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share of Global, 2018-2029

Figure 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2022

Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 15. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain

Figure 16. Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model

Figure 17. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model

Figure 18. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution

Figure 19. Class 1 Vaccine

Figure 20. Class II Vaccine

Figure 21. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 24. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 26. Hospital

Figure 27. Clinic

Figure 28. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million

Figure 29. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029

Figure 30. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 31. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029

Figure 32. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 33. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029

Figure 34. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029

Figure 35. North America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 36. By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022

Figure 37. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 38. By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022

Figure 39. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022

Figure 41. South America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022

Figure 43. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 45. By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 46. By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 47. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 50. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 53. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 56. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 59. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 62. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 65. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 68. Research Methodology

Figure 69. Breakdown of Primary Interviews

Figure 70. Bottom-up and Top-down Approaches

Figure 71. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)